<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">Inflammatory bowel diseases</z:e> (IBD) can be really considered to be <z:e sem="disease" ids="C0442893" disease_type="Disease or Syndrome" abbrv="">systemic diseases</z:e> since they are often associated with extraintestinal manifestations, complications, and other <z:hpo ids='HP_0002960'>autoimmune disorders</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Indeed, physicians who care for patients with <z:hpo ids='HP_0100279'>ulcerative colitis</z:hpo> and <z:hpo ids='HP_0100280'>Crohn's disease</z:hpo>, the two major forms of IBD, face a new clinical challenge every day, worsened by the very frequent rate of extraintestinal complications </plain></SENT>
<SENT sid="2" pm="."><plain>The goal of this review is to provide an overview and an update on the extraintestinal complications occurring in IBD </plain></SENT>
<SENT sid="3" pm="."><plain>Indeed, this paper highlights how virtually almost every organ system can be involved, principally eyes, skin, joints, kidneys, liver and biliary tracts, and vasculature (or vascular system) are the most common sites of systemic IBD and their involvement is dependent on different mechanisms </plain></SENT>
</text></document>